ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Blueprint Medicines Corporation

Blueprint Medicines Corporation (BPMC)

112,53
-1,52
(-1,33%)
Fermé 01 Février 10:00PM
112,53
0,14
(0,12%)
Après les heures de négociation: 11:30PM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
112,53
Prix Achat
111,00
Prix Vente
120,00
Volume échangé
578 555
112,18 Fourchette du Jour 116,23
72,24 Plage de 52 semaines 121,90
Cap du marché
Clôture Veille
114,05
Ouverture
114,49
Dernière Transaction
2
@
111
Dernière heure de transaction
Volume financier
US$ 65 719 457
VWAP
113,5924
Volume moyen (3 m)
707 041
Actions en circulation
63 525 838
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-14,08
Bénéfice par action (BPA)
-7,98
Chiffre d'affairess
249,38M
Bénéfice net
-506,98M

À propos de Blueprint Medicines Corporation

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates BLU-285, which targets KIT ... Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates BLU-285, which targets KIT Exon 17 mutants and PDGFRa D842V, abnormally active receptor tyrosine kinase mutants that are drivers of cancer and proliferative disorders. Its other drug candidate is BLU 554 FOR Advanced Hepatocellular Carcinoma, and BLU-667 for Ret Mutations, Fusions, and Predicted Resistant Mutants. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Wilmington, Delaware, USA
Fondé
-
Blueprint Medicines Corporation est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker BPMC. Le dernier cours de clôture d'Blueprint Medicines était de US$114,05. Au cours de la dernière année, les actions de Blueprint Medicines ont été négociées dans une fourchette de prix de US$ 72,24 à US$ 121,90.

Blueprint Medicines compte actuellement 63 525 838 actions en circulation. La capitalisation boursière d'Blueprint Medicines est de US$7,25 milliard. Blueprint Medicines a un ratio cours/bénéfice (ratio PE) de -14.08.

Flux d'options Blueprint Medicines (BPMC)

Flux global

Baissier

Prime nette

-142k

Calls / Puts

0,00%

Ach. / Vent.

33,33%

OTM / ITM

100,00%

Sweeps Ratio

0,00%

BPMC Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-2.22-1.93464052288114.75118.25112.39778331114.25871092CS
425.4929.285386029487.04118.2586.72944404103.76802844CS
1211.0310.8669950739101.5118.2585.9170704197.66918437CS
264.724.37807253502107.81118.2580.67569604894.12829159CS
5229.2535.122478386283.28121.972.2470151095.48356492CS
15641.3458.069953645271.19121.937.8270384470.70778823CS
26048.3875.416991426364.15125.6137.8262652975.25326206CS

BPMC - Frequently Asked Questions (FAQ)

What is the current Blueprint Medicines share price?
The current share price of Blueprint Medicines is US$ 112,53
How many Blueprint Medicines shares are in issue?
Blueprint Medicines has 63 525 838 shares in issue
What is the market cap of Blueprint Medicines?
The market capitalisation of Blueprint Medicines is USD 7,25B
What is the 1 year trading range for Blueprint Medicines share price?
Blueprint Medicines has traded in the range of US$ 72,24 to US$ 121,90 during the past year
What is the PE ratio of Blueprint Medicines?
The price to earnings ratio of Blueprint Medicines is -14,08
What is the cash to sales ratio of Blueprint Medicines?
The cash to sales ratio of Blueprint Medicines is 28,63
What is the reporting currency for Blueprint Medicines?
Blueprint Medicines reports financial results in USD
What is the latest annual turnover for Blueprint Medicines?
The latest annual turnover of Blueprint Medicines is USD 249,38M
What is the latest annual profit for Blueprint Medicines?
The latest annual profit of Blueprint Medicines is USD -506,98M
What is the registered address of Blueprint Medicines?
The registered address for Blueprint Medicines is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Blueprint Medicines website address?
The website address for Blueprint Medicines is www.blueprintmedicines.com
Which industry sector does Blueprint Medicines operate in?
Blueprint Medicines operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
TCTMTCTM Kids IT Education Inc
US$ 0,764
(321,87%)
729,71M
REBNReborn Coffee Inc
US$ 3,31
(63,05%)
55,54M
FCUVFocus Universal Inc
US$ 5,87
(56,62%)
1,73M
SOPASociety Pass Inc
US$ 1,54
(56,50%)
13,82M
CYCNCyclerion Therapeutics Inc
US$ 3,92
(54,33%)
82,39M
ENVBEnveric Biosciences Inc
US$ 2,0899
(-46,41%)
1,58M
NIVFNewGenIvf Group Ltd
US$ 0,1489
(-42,51%)
14,91M
GLSTGlobal Star Acquisition Inc
US$ 8,83
(-39,10%)
23,93k
PRPHProPhase Labs Inc
US$ 0,2633
(-38,02%)
900,48k
SPGCSacks Parente Golf Inc
US$ 0,5601
(-37,86%)
7,42M
TCTMTCTM Kids IT Education Inc
US$ 0,764
(321,87%)
729,71M
NVDANVIDIA Corporation
US$ 120,07
(-3,67%)
388,53M
RIMEAlgorhythm Holdings Inc
US$ 0,02565
(5,12%)
338,7M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0355
(-11,25%)
236,05M
CLEUChina Liberal Education Holdings Ltd
US$ 0,1938
(30,77%)
234,74M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock